Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Gains from Investment Securities (2023 - 2025)

Immunome's Gains from Investment Securities history spans 3 years, with the latest figure at -$55000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 104.63% year-over-year to -$55000.0; the TTM value through Dec 2025 reached $5.7 million, changed N/A, while the annual FY2025 figure was $1.1 million, 83.83% down from the prior year.
  • Gains from Investment Securities reached -$55000.0 in Q4 2025 per IMNM's latest filing, down from $1.1 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $5.8 million in Q4 2023 to a low of -$55000.0 in Q4 2025.
  • Average Gains from Investment Securities over 3 years is $1.9 million, with a median of $1.1 million recorded in 2024.
  • Peak YoY movement for Gains from Investment Securities: skyrocketed 5166.42% in 2024, then crashed 104.63% in 2025.
  • A 3-year view of Gains from Investment Securities shows it stood at $5.8 million in 2023, then crashed by 79.5% to $1.2 million in 2024, then plummeted by 104.63% to -$55000.0 in 2025.
  • Per Business Quant, the three most recent readings for IMNM's Gains from Investment Securities are -$55000.0 (Q4 2025), $1.1 million (Q3 2025), and $578980.0 (Q2 2025).